RARE Ultragenyx Pharmaceutical Inc.
$17.73
Ultragenyx Pharmaceutical Inc. (RARE) Earnings News
Earnings press releases, previews and reviews for Ultragenyx Pharmaceutical Inc. (RARE), newest first. Our most recent is review: Ultragenyx Misses on Revenue, but Gene Therapy Approvals, $350 Million in Voucher Proceeds and Deep Cuts Push It Toward Profitability.
Tuesday
November 3, 2026
7:44 PM ET
Ultragenyx Misses on Revenue, but Gene Therapy Approvals, $350 Million in Voucher Proceeds and Deep Cuts Push It Toward Profitability
Earnings Whispers · Review
Tuesday
November 3, 2026
4:01 PM ET
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
Tuesday
October 27, 2026
8:37 PM ET
Ultragenyx Faces a Credibility Test as Catalyst Season Collides With a 43% Selloff
Earnings Whispers · Preview
Tuesday
October 27, 2026
4:05 PM ET
Ultragenyx to Host Conference Call for Third Quarter 2026 Financial Results and Corporate Update
Tuesday
August 4, 2026
4:05 PM ET
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
Tuesday
July 28, 2026
4:05 PM ET
Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update